Researchers from Sapporo Medical University, School of Medicine in Hokkaido, Japan, recently completed and published the results of a study involving the antiviral drug favipiravir…
Morimasa Yagisawa, visiting professor at Kitasato University, Omura Satoshi Memorial Institute in Tokyo, went on the record that the World Health Organization, drug regulators, and…
FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Toyama Chemical; President: Junji Okada) has announced the initiation of a new phase III clinical trial in Japan concerning…
Individuals from SoftBank Group Corp frequent the TrialSite News website on a daily basis. Clearly, there are individuals interested in the particular site and transparency perspective…
Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: Back in May 2020, TrialSite…
Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for COVID-19 alongside remdesivir (Gilead’s Veklury)…
On February 9th a prominent member of the medical establishment here came out in a very public manner in favor of ivermectin as a treatment for…
The fast-track approval, made by the Ministry of Health, Labor and Welfare, represents a major step forward in Japan’s efforts to bring the pandemic under…
The Tokyo Metropolitan Government announced plans to conduct clinical trials investigating the use of Ivermectin at metropolitan and public hospitals to evaluate the anti-parasitic drug’s…
Why let promising drugs exhibiting benefit stall in the market? In a bid to counter such trends, and even accelerate drug approvals, Japan’s health ministry will…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
